21 U.S.C. § 812 : US Code - Section 812: Schedules of controlled substances

Search 21 U.S.C. § 812 : US Code - Section 812: Schedules of controlled substances

    (a) Establishment
      There are established five schedules of controlled substances, to
    be known as schedules I, II, III, IV, and V. Such schedules shall
    initially consist of the substances listed in this section. The
    schedules established by this section shall be updated and
    republished on a semiannual basis during the two-year period
    beginning one year after October 27, 1970, and shall be updated and
    republished on an annual basis thereafter.
    (b) Placement on schedules; findings required
      Except where control is required by United States obligations
    under an international treaty, convention, or protocol, in effect
    on October 27, 1970, and except in the case of an immediate
    precursor, a drug or other substance may not be placed in any
    schedule unless the findings required for such schedule are made
    with respect to such drug or other substance. The findings required
    for each of the schedules are as follows:
      (1) Schedule I. - 
        (A) The drug or other substance has a high potential for abuse.
        (B) The drug or other substance has no currently accepted
      medical use in treatment in the United States.
        (C) There is a lack of accepted safety for use of the drug or
      other substance under medical supervision.

      (2) Schedule II. - 
        (A) The drug or other substance has a high potential for abuse.
        (B) The drug or other substance has a currently accepted
      medical use in treatment in the United States or a currently
      accepted medical use with severe restrictions.
        (C) Abuse of the drug or other substances may lead to severe
      psychological or physical dependence.

      (3) Schedule III. - 
        (A) The drug or other substance has a potential for abuse less
      than the drugs or other substances in schedules I and II.
        (B) The drug or other substance has a currently accepted
      medical use in treatment in the United States.
        (C) Abuse of the drug or other substance may lead to moderate
      or low physical dependence or high psychological dependence.

      (4) Schedule IV. - 
        (A) The drug or other substance has a low potential for abuse
      relative to the drugs or other substances in schedule III.
        (B) The drug or other substance has a currently accepted
      medical use in treatment in the United States.
        (C) Abuse of the drug or other substance may lead to limited
      physical dependence or psychological dependence relative to the
      drugs or other substances in schedule III.

      (5) Schedule V. - 
        (A) The drug or other substance has a low potential for abuse
      relative to the drugs or other substances in schedule IV.
        (B) The drug or other substance has a currently accepted
      medical use in treatment in the United States.
        (C) Abuse of the drug or other substance may lead to limited
      physical dependence or psychological dependence relative to the
      drugs or other substances in schedule IV.
    (c) Initial schedules of controlled substances
      Schedules I, II, III, IV, and V shall, unless and until amended
    (!1) pursuant to section 811 of this title, consist of the
    following drugs or other substances, by whatever official name,
    common or usual name, chemical name, or brand name designated:


                                SCHEDULE I                            
      (a) Unless specifically excepted or unless listed in another
    schedule, any of the following opiates, including their isomers,
    esters, ethers, salts, and salts of isomers, esters, and ethers,
    whenever the existence of such isomers, esters, ethers, and salts
    is possible within the specific chemical designation:
        (1) Acetylmethadol.
        (2) Allylprodine.
        (3) Alphacetylmathadol.(!2)

        (4) Alphameprodine.
        (5) Alphamethadol.
        (6) Benzethidine.
        (7) Betacetylmethadol.
        (8) Betameprodine.
        (9) Betamethadol.
        (10) Betaprodine.
        (11) Clonitazene.
        (12) Dextromoramide.
        (13) Dextrorphan.
        (14) Diampromide.
        (15) Diethylthiambutene.
        (16) Dimenoxadol.
        (17) Dimepheptanol.
        (18) Dimethylthiambutene.
        (19) Dioxaphetyl butyrate.
        (20) Dipipanone.
        (21) Ethylmethylthiambutene.
        (22) Etonitazene.
        (23) Etoxeridine.
        (24) Furethidine.
        (25) Hydroxypethidine.
        (26) Ketobemidone.
        (27) Levomoramide.
        (28) Levophenacylmorphan.
        (29) Morpheridine.
        (30) Noracymethadol.
        (31) Norlevorphanol.
        (32) Normethadone.
        (33) Norpipanone.
        (34) Phenadoxone.
        (35) Phenampromide.
        (36) Phenomorphan.
        (37) Phenoperidine.
        (38) Piritramide.
        (39) Propheptazine.
        (40) Properidine.
        (41) Racemoramide.
        (42) Trimeperidine.

      (b) Unless specifically excepted or unless listed in another
    schedule, any of the following opium derivatives, their salts,
    isomers, and salts of isomers whenever the existence of such salts,
    isomers, and salts of isomers is possible within the specific
    chemical designation:
        (1) Acetorphine.
        (2) Acetyldihydrocodeine.
        (3) Benzylmorphine.
        (4) Codeine methylbromide.
        (5) Codeine-N-Oxide.
        (6) Cyprenorphine.
        (7) Desomorphine.
        (8) Dihydromorphine.
        (9) Etorphine.
        (10) Heroin.
        (11) Hydromorphinol.
        (12) Methyldesorphine.
        (13) Methylhydromorphine.
        (14) Morphine methylbromide.
        (15) Morphine methylsulfonate.
        (16) Morphine-N-Oxide.
        (17) Myrophine.
        (18) Nicocodeine.
        (19) Nicomorphine.
        (20) Normorphine.
        (21) Pholcodine.
        (22) Thebacon.

      (c) Unless specifically excepted or unless listed in another
    schedule, any material, compound, mixture, or preparation, which
    contains any quantity of the following hallucinogenic substances,
    or which contains any of their salts, isomers, and salts of isomers
    whenever the existence of such salts, isomers, and salts of isomers
    is possible within the specific chemical designation:
        (1) 3,4-methylenedioxy amphetamine.
        (2) 5-methoxy-3,4-methylenedioxy amphetamine.
        (3) 3,4,5-trimethoxy amphetamine.
        (4) Bufotenine.
        (5) Diethyltryptamine.
        (6) Dimethyltryptamine.
        (7) 4-methyl-2,5-diamethoxyamphetamine.
        (8) Ibogaine.
        (9) Lysergic acid diethylamide.
        (10) Marihuana.
        (11) Mescaline.
        (12) Peyote.
        (13) N-ethyl-3-piperidyl benzilate.
        (14) N-methyl-3-piperidyl benzilate.
        (15) Psilocybin.
        (16) Psilocyn.
        (17) Tetrahydrocannabinols.
                                SCHEDULE II                            
      (a) Unless specifically excepted or unless listed in another
    schedule, any of the following substances whether produced directly
    or indirectly by extraction from substances of vegetable origin, or
    independently by means of chemical synthesis, or by a combination
    of extraction and chemical synthesis:
        (1) Opium and opiate, and any salt, compound, derivative, or
      preparation of opium or opiate.
        (2) Any salt, compound, derivative, or preparation thereof
      which is chemically equivalent or identical with any of the
      substances referred to in clause (1), except that these
      substances shall not include the isoquinoline alkaloids of opium.
        (3) Opium poppy and poppy straw.
        (4) coca (!3) leaves, except coca leaves and extracts of coca
      leaves from which cocaine, ecgonine, and derivatives of ecgonine
      or their salts have been removed; cocaine, its salts, optical and
      geometric isomers, and salts of isomers; ecgonine, its
      derivatives, their salts, isomers, and salts of isomers; or any
      compound, mixture, or preparation which contains any quantity of
      any of the substances referred to in this paragraph.


      (b) Unless specifically excepted or unless listed in another
    schedule, any of the following opiates, including their isomers,
    esters, ethers, salts, and salts of isomers, esters and ethers,
    whenever the existence of such isomers, esters, ethers, and salts
    is possible within the specific chemical designation:
        (1) Alphaprodine.
        (2) Anileridine.
        (3) Bezitramide.
        (4) Dihydrocodeine.
        (5) Diphenoxylate.
        (6) Fentanyl.
        (7) Isomethadone.
        (8) Levomethorphan.
        (9) Levorphanol.
        (10) Metazocine.
        (11) Methadone.
        (12) Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-
      diphenyl butane.
        (13) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-
      diphenylpropane-carboxylic acid.
        (14) Pethidine.
        (15) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-
      phenylpiperidine.
        (16) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-
      carboxylate.
        (17) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-
      carboxylic acid.
        (18) Phenazocine.
        (19) Piminodine.
        (20) Racemethorphan.
        (21) Racemorphan.

      (c) Unless specifically excepted or unless listed in another
    schedule, any injectable liquid which contains any quantity of
    methamphetamine, including its salts, isomers, and salts of
    isomers.
                               SCHEDULE III                           
      (a) Unless specifically excepted or unless listed in another
    schedule, any material, compound, mixture, or preparation which
    contains any quantity of the following substances having a
    stimulant effect on the central nervous system:
        (1) Amphetamine, its salts, optical isomers, and salts of its
      optical isomers.
        (2) Phenmetrazine and its salts.
        (3) Any substance (except an injectable liquid) which contains
      any quantity of methamphetamine, including its salts, isomers,
      and salts of isomers.
        (4) Methylphenidate.

      (b) Unless specifically excepted or unless listed in another
    schedule, any material, compound, mixture, or preparation which
    contains any quantity of the following substances having a
    depressant effect on the central nervous system:
        (1) Any substance which contains any quantity of a derivative
      of barbituric acid, or any salt of a derivative of barbituric
      acid.
        (2) Chorhexadol.
        (3) Glutethimide.
        (4) Lysergic acid.
        (5) Lysergic acid amide.
        (6) Methyprylon.
        (7) Phencyclidine.
        (8) Sulfondiethylmethane.
        (9) Sulfonethylmethane.
        (10) Sulfonmethane.

      (c) Nalorphine.
      (d) Unless specifically excepted or unless listed in another
    schedule, any material, compound, mixture, or preparation
    containing limited quantities of any of the following narcotic
    drugs, or any salts thereof:
        (1) Not more than 1.8 grams of codeine per 100 milliliters or
      not more than 90 milligrams per dosage unit, with an equal or
      greater quantity of an isoquinoline alkaloid of opium.
        (2) Not more than 1.8 grams of codeine per 100 milliliters or
      not more than 90 milligrams per dosage unit, with one or more
      active, non-narcotic ingredients in recognized therapeutic
      amounts.
        (3) Not more than 300 milligrams of dihydrocodeinone per 100
      milliliters or not more than 15 milligrams per dosage unit, with
      a fourfold or greater quantity of an isoquinoline alkaloid of
      opium.
        (4) Not more than 300 milligrams of dihydrocodeinone per 100
      milliliters or not more than 15 milligrams per dosage unit, with
      one or more active, nonnarcotic ingredients in recognized
      therapeutic amounts.
        (5) Not more than 1.8 grams of dihydrocodeine per 100
      milliliters or not more than 90 milligrams per dosage unit, with
      one or more active, nonnarcotic ingredients in recognized
      therapeutic amounts.
        (6) Not more than 300 milligrams of ethylmorphine per 100
      milliliters or not more than 15 milligrams per dosage unit, with
      one or more active, nonnarcotic ingredients in recognized
      therapeutic amounts.
        (7) Not more than 500 milligrams of opium per 100 milliliters
      or per 100 grams, or not more than 25 milligrams per dosage unit,
      with one or more active, nonnarcotic ingredients in recognized
      therapeutic amounts.
        (8) Not more than 50 milligrams of morphine per 100 milliliters
      or per 100 grams with one or more active, nonnarcotic ingredients
      in recognized therapeutic amounts.

      (e) Anabolic steroids.
                                SCHEDULE IV                            
      (1) Barbital.
      (2) Chloral betaine.
      (3) Chloral hydrate.
      (4) Ethchlorvynol.
      (5) Ethinamate.
      (6) Methohexital.
      (7) Meprobamate.
      (8) Methylphenobarbital.
      (9) Paraldehyde.
      (10) Petrichloral.
      (11) Phenobarbital.
                                SCHEDULE V                            
      Any compound, mixture, or preparation containing any of the
    following limited quantities of narcotic drugs, which shall include
    one or more nonnarcotic active medicinal ingredients in sufficient
    proportion to confer upon the compound, mixture, or preparation
    valuable medicinal qualities other than those possessed by the
    narcotic drug alone:
        (1) Not more than 200 milligrams of codeine per 100 milliliters
      or per 100 grams.
        (2) Not more than 100 milligrams of dihydrocodeine per 100
      milliliters or per 100 grams.
        (3) Not more than 100 milligrams of ethylmorphine per 100
      milliliters or per 100 grams.
        (4) Not more than 2.5 milligrams of diphenoxylate and not less
      than 25 micrograms of atropine sulfate per dosage unit.
        (5) Not more than 100 milligrams of opium per 100 milliliters
      or per 100 grams.